
People with motor neurone disease (MND) could be offered drugs to treat the disease faster under a new initiative.
The scheme across the UK will screen candidate drugs rapidly in a bid to identify which should be tested in larger clinical trials.

People with motor neurone disease (MND) could be offered drugs to treat the disease faster under a new initiative.
The scheme across the UK will screen candidate drugs rapidly in a bid to identify which should be tested in larger clinical trials.